Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Fresnillo shares drop on cautious silver outlook

(Sharecast News) - Precious metals miner Fresnillo reported a "robust" period for production in the second quarter and said that gold output was trending towards the upper end of full-year guidance, though silver results have been weaker than hoped. Attributable gold production is expected to come in at the higher end of the 525,000-580,000-ounce target range.

Silver output should still meet the 49m-56m-ounce guidance, "albeit impacted by the weaker Silverstream contribution and lower grades at the Fresnillo mine", according to chief executive Octavio Alvídrez.

Quarterly attributable silver production totalled 12.5m ounces in the second quarter, up 1% over the first quarter but down 14.7% over the year before, with mining activities finishing at San Julián DOB, lower ore grades and decreased recovery rates at Ciénega, and lower ore grades at Juanicipio.

As a result, first-half silver output of 24.9m ounces was down 11.8% on last year.

Gold production was also 1% higher than the first quarter at 157,700 ounces, but 21.3% higher than the last year, resulting in a 15.9% increase in first-half output to 313,800 ounces.

In terms of by-products, lead production was up "slightly" on the first quarter, while zinc production rose 12.5%.

Alvídrez said: "I am pleased to report another quarter of robust silver and gold production, reflecting the resilience and dedication of our teams and consistent performance of our operating mines [...] Our rigorous focus on operational optimisation and cost reduction initiatives continues to yield positive results, combined with favourable precious metals prices."

Fresnillo shares were down nearly 3% at 1,423p by 0815 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.